Snowball logo
logo
6005

Kangmei Pharmaceutical Co Ltd

600518 SHG
¥1.45+¥0.01  (0.69%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
4,152.54,180.24,8745,189.15,252.25,018.6
COGS
4,0613,7494,145.24,535.84,203.13,981.5
Gross Profit
91.52431.1728.9653.41,049.11,037
Operating Expenses & Income
Operating Income
10,110.9(1,777.5)86.67(24.79)111.7116
Total Operating Expenses
(10,019.4)2,208.7642.2678.25,140.52,760.9
R&D Expenses
9.27312725.4545.6251.4645.3345.68
Selling General & Admin Expenses
820.2561.2490.2530.7321.11,065.1
Earnings from Continuing Operations
Interest Expense
(1,022)(80.86)(57.86)(22.41)(18.67)(18.28)
Interest Income
5.27128440.0330.7417.2310.59.1759
Income Tax Expense
235.429.756.79967722.57-11.79
Net Income
Net Income
7,917.9(2,688.2)102.58.57366910.33(14.74)
Supplemental
EBIT
(3,046.5)(1,040.3)179.6(413.5)--
EBITDA
(2,493.3)(730.4)470.9(131.8)--
In millions of CNY, except % and values per 1 share